Ads block
Showing posts with label Health. Show all posts
Showing posts with label Health. Show all posts
The American Cancer Society is recommending men aged 50 to 69, and some even younger, get screened regularly for prostate cancer
With improved treatment, the benefits could now outweigh the harms of widespread testing for middle-aged men. Read Full Story →
Read more »
For the superrich, concierge doctors, biohacking retreats and AI-driven wellness routines are part of the pursuit of longevity
Concierge doctors, biohacking retreats and AI-driven wellness routines are part of the pursuit of longevity for the superrich. Read Full Story →
Read more »
Novo Nordisk Lifts Guidance as Rollout of Wegovy Weight-Loss Pill Continues
The Danish drugmaker raised its guidance for the year after noting an improved outlook for its key obesity and diabetes drugs, particularly in markets outside …
Read more »
The Trump administration’s international drug-price policy hasn’t appeared to temper the price of new drugs in the U.S. yet. But Europe has had fewer drug launches.
An analysis shows that 27% fewer drugs launched in Europe since President Trump’s international drug-pricing policy began. Read Full Story →
Read more »
As federal regulators move to ban 7-OH products, doctors say medications used to treat opioid addiction can be effective treatments
As federal regulators move to restrict 7-OH products, doctors say medications used to treat opioid addiction can help people dependent on the potent kratom der…
Read more »
The Trump administration’s international drug-price policy hasn’t appeared to temper the price of new drugs in the U.S. yet. But Europe has had fewer drug launches.
An analysis shows that 27% fewer drugs launched in Europe since President Trump’s international drug-pricing policy began. Read Full Story →
Read more »
AstraZeneca recently made a roughly $10 billion offer to buy Rhythm Pharmaceuticals, a deal that would expand its portfolio of rare disease treatments
Rhythm specializes in treatments for metabolic conditions and severe obesity. Read Full Story →
Read more »
Pills can be hard to swallow, powders can be messy and gummies can be sugary. Enter the buzzy business of supplement strips.
Like breath strips, they dissolve on the tongue, claiming a faster way to better sleep, healthier skin and other benefits. Read Full Story →
Read more »
Inside CVS Health, a small group of top executives spent months engaged in a strategic review that developed into a secret plan: a decision to split up the $400 billion healthcare giant
The company is splitting its drugstore and insurance businesses amid mounting regulatory pressure. Read Full Story →
Read more »
RFK Jr. is temporarily allowing six unapproved peptides on the market, despite warnings from government scientists that there isn’t enough evidence to prove they are safe or effective
Experts have warned there isn’t sufficient evidence showing peptides are safe or effective. Read Full Story →
Read more »
Elevance Health sued autism-therapy provider the Perfect Child, alleging that it paid the company $160 million due to misleading claims over the last five years
Elevance Health claims the Perfect Child used LLCs to charge out-of-network rates. Read Full Story →
Read more »
Elevance Health sued autism-therapy provider the Perfect Child, alleging that it paid the company $160 million due to misleading claims over the last five years
Elevance Health claims the Perfect Child used LLCs to charge out-of-network rates. Read Full Story →
Read more »
Novo Nordisk Lifts Guidance as Rollout of Wegovy Weight-Loss Pill Continues
The Danish drugmaker raised its guidance for the year after noting an improved outlook for its key obesity and diabetes drugs, particularly in markets outside …
Read more »
Entering your 40s increasingly means starting another full-time job: Pretending you can still see.
Vision loss hits almost everyone, but it’s proving particularly traumatic for a generation in full denial of the aging process. Read Full Story →
Read more »
Moderna’s CEO told The Wall Street Journal that his cancer vaccine’s data will get better with time, and that no one can easily copy the company’s work
Stéphane Bancel defended his melanoma data and argued that rivals can’t easily copy the technology. Read Full Story →
Read more »
Genmab Shares Jump After Positive Cancer Study Results
The Danish biotech said an experimental drug cut the risk of death and disease progression for ovarian-cancer patients in a late-stage clinical trial. Read Ful…
Read more »
Eli Lilly Revenue Climbs on Demand for Obesity Drugs
The pharmaceutical company’s third-quarter profit came in at $6.45 billion, or $7.22 a share, compared with $5.58 billion, or $6.21 a share, a year earlier. Re…
Read more »
Eli Lilly Revenue Climbs on Demand for Obesity Drugs
The pharmaceutical company’s third-quarter profit came in at $6.45 billion, or $7.22 a share, compared with $5.58 billion, or $6.21 a share, a year earlier. Re…
Read more »
GSK Sees Cancer-Drug Pipeline Nearly Doubling Next Year After Dealmaking Spree
EXCLUSIVE: The U.K. drugmaker currently has five approved cancer medicines and a clinical-stage portfolio of about 15 assets. Read Full Story →
Read more »
Eli Lilly Revenue Climbs on Demand for Obesity Drugs
The pharmaceutical company’s third-quarter profit came in at $6.45 billion, or $7.22 a share, compared with $5.58 billion, or $6.21 a share, a year earlier. Re…
Read more »
-
Our global transition to renewable energy sources like solar and wind is critical for combating climate change. However, these sources a...
-
F ree For Dev elopers Many services now offer free tiers for developers and open-source creators, but finding them all can be time-consumi...
-
Large Language Models (LLMs) function as sophisticated statistical prediction machines built upon a neural network architecture called ...
Subscribe Us
Click a video to watch:
